Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06256276 · ClinicalTrials.gov registry record · NA

Nutritional Therapy for Autonomic Dysfunction in Elderly Heart Failure Patients

A NA study of Heart Failure, sponsored by University of Arkansas.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT06256276 is a NA study of Heart Failure that has completed, run by University of Arkansas. The registered enrollment target is 21 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06256276, a NA study of Heart Failure, has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

Recent studies suggest that patients with heart failure (HF) may have a reduced ability to control the tone of their blood vessels, heart rate or blood pressure in response to stress. This study will test whether 16 weeks of protein supplements can improve control of blood pressure and heart rate in HF patients.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Whey protein powder and L-carnitine
  • DIETARY_SUPPLEMENT Maltodextrin placebo powder and Psyllium Husk capsules

Study Locations (1)

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2016-07-26
Est. Completion 2018-02-01
Phase NA

Sponsor

University of Arkansas

318 total trials

What the Registry Record Tells You About NCT06256276

The ClinicalTrials.gov registry entry for NCT06256276 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Whey protein powder and L-carnitine is the first listed.

NCT06256276 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.

Frequently Asked Questions

What is clinical trial NCT06256276 about?

NCT06256276 is a clinical study titled "Nutritional Therapy for Autonomic Dysfunction in Elderly Heart Failure Patients". Recent studies suggest that patients with heart failure (HF) may have a reduced ability to control the tone of their blood vessels, heart rate or blood pressure in response to stress. This study will test whether 16 weeks of protein supplements can improve control of blood pressure and heart rate in...

What is the current status of trial NCT06256276?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2016-07-26. Estimated completion is 2018-02-01.

What conditions does trial NCT06256276 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT06256276?

The interventions under investigation include: Whey protein powder and L-carnitine (DIETARY_SUPPLEMENT), Maltodextrin placebo powder and Psyllium Husk capsules (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06256276?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06256276 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.